Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|March 11, 2024

Screening and Diagnosing of Ph+ ALL in Adults

The panel discusses optimal strategies for screening and detecting Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in patients across different treatment stages.

Episodes in this series

EP. 1 Overview of Characteristics Unique to Ph+ ALL

EP. 1 Overview of Characteristics Unique to Ph+ ALL

EP. 2 Timely Detection: Incidence and Prevalence of Ph+ ALL

EP. 2 Timely Detection: Incidence and Prevalence of Ph+ ALL

EP. 3 Supporting Ph+ ALL Patient: Emotional Challenges and Quality of Life

EP. 3 Supporting Ph+ ALL Patient: Emotional Challenges and Quality of Life

Video 4 - "Screening and Diagnosing of Ph+ ALL in Adults"

EP. 4 Screening and Diagnosing of Ph+ ALL in Adults

Video 5 - "Diagnosis and Treatment Timeline: Different Phases of Ph+ ALL Management"

EP. 5 Diagnosis and Treatment Timeline: Different Phases of Ph+ ALL Management

Video 6 - "Current Front-Line Targeted Treatments in Ph+ ALL"

EP. 6 Current Front-Line Targeted Treatments in Ph+ ALL

Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"

EP. 7 Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients

Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"

EP. 8 PhALLCON Trial: Efficacy and Safety of Ponatinib in Ph+ ALL Patients

Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"

EP. 9 Value-Based Care Models Optimizing Ph+ ALL Patient Care

VIdeo 10 - "Unmet Needs in Screening, Diagnosis, and Management of Ph+ ALL"

EP. 10 Unmet Needs in Screening, Diagnosis, and Management of Ph+ ALL

Video 11 - "Disparities in Access to Care for Ph+ ALL patients"

EP. 11 Disparities in Access to Care for Ph+ ALL patients

Video 12 - "The Future of Ph+ ALL Treatments"

EP. 12 The Future of Ph+ ALL Treatments

Video 13 - "Concluding Thoughts on Ph+ ALL Treatment"

EP. 13 Concluding Thoughts on Ph+ ALL Treatment

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Committee meeting | Image credit: Open Horizon - stock.adobe.com

FDA Advisory Panel Votes Against Approval of Deramiocel for DMD

ByPearl Steinzor

July 30th 2026

MRI of the brain | Image Credit: DedMityay - stock.adobe.com

MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds

ByBrooke McCormick

July 30th 2026

Chronic hand eczema. | Image Credit: IIIRusya - stock.adobe.com

Delgocitinib Cream Succeeds in First Phase 3 Trial for Teens With Hand Eczema

BySkylar Jeremias

July 30th 2026

Nitipong Permpalung, MD

Early Remdesivir May Reduce Graft Loss in Kidney Transplant Recipients With COVID-19: Nitipong Permpalung, MD, MPH

BySabrina McCrear,Nitipong Permpalung, MD, MPH

July 30th 2026

ALL Graphic | Image Credit: Sviatlana - stock.adobe.com

B-ALL Data Reinforce Push for Risk-Tailored Care

ByMaggie L. Shaw

July 30th 2026

Trending on AJMC

Judge Denies Preliminary Injunction in Medicaid Work Requirements Case

Wildfire Smoke Raises Asthma Risks as Fires Worsen Air Quality Across North America

Can Oral Semaglutide Reduce Heavy Drinking in Alcohol Use Disorder?

Hepatitis B Virus Vaccines Underperform in People Living With HIV

Contributor: Artificial Intelligence Grows Across Health Care, Led by Administrative Processes